title: Coronary artery disease: how should the STICH trial results affect clinical practice?
abstract: The STICH trial showed that CABG surgery does not necessarily improve cardiovascular outcomes in patients with coronary artery disease and left ventricular dysfunction who are receiving optimal medical therapy. However, surgical revascularization should still be considered if the coronary artery disease is severe and viable myocardium can be identified.
authors: Baylor Health Care System, 1100 Allied Drive, Plano, TX 75075, USA. michaema@baylorhealth.edu
authors: Michael J
authors: MJ
authors: Mack
mesh_terms: D002317:Cardiovascular Agents / Q000627:therapeutic use*; D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000150:complications / Q000628:therapy*; D019317:Evidence-Based Medicine; D006801:Humans; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000150:complications / Q000628:therapy*
chemical_list: D002317:Cardiovascular Agents